Involving the Introduction of Recombinant or Synthetic Nucleic Acid Molecules, Potential Infectious Agents/Pathogens, and/or Biological Toxins in Human Subjects
Studies that involve the use of recombinant or synthetic nucleic acid molecules, potentially infectious or pathogenic agents, biological toxins in human subjects must be reviewed and approved by the Institutional Biosafety Committee (IBC).
Investigators who intend to submit a human pathogen or gene transfer protocol to the Johns Hopkins Institutional Review Board (IRB) should contact [email protected] for IBC submission details.